Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Accounts Payable (Quarterly): 24.85M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 24.85M |
June 30, 2023 | 18.44M |
March 31, 2023 | 32.26M |
December 31, 2022 | 45.35M |
September 30, 2022 | 20.18M |
June 30, 2022 | 17.24M |
March 31, 2022 | 16.06M |
December 31, 2021 | 18.43M |
September 30, 2021 | 10.52M |
June 30, 2021 | 11.63M |
March 31, 2021 | 12.92M |
December 31, 2020 | 9.538M |
September 30, 2020 | 8.913M |
June 30, 2020 | 12.74M |
March 31, 2020 | 9.534M |
December 31, 2019 | 9.933M |
September 30, 2019 | 7.227M |
June 30, 2019 | 7.809M |
March 31, 2019 | 8.777M |
December 31, 2018 | 11.36M |
September 30, 2018 | 10.35M |
June 30, 2018 | 12.88M |
March 31, 2018 | 7.786M |
December 31, 2017 | 8.562M |
September 30, 2017 | 6.614M |
Date | Value |
---|---|
June 30, 2017 | 5.152M |
March 31, 2017 | 5.10M |
September 30, 2016 | 8.973M |
June 30, 2016 | 11.51M |
March 31, 2016 | 10.10M |
December 31, 2015 | 13.40M |
September 30, 2015 | 9.689M |
June 30, 2015 | 8.138M |
March 31, 2015 | 6.322M |
December 31, 2014 | 5.613M |
September 30, 2014 | 4.957M |
June 30, 2014 | 4.819M |
March 31, 2014 | 4.743M |
December 31, 2013 | 3.812M |
September 30, 2013 | 3.122M |
June 30, 2013 | 4.498M |
March 31, 2013 | 2.723M |
December 31, 2012 | 4.706M |
September 30, 2012 | 3.216M |
June 30, 2012 | 3.395M |
March 31, 2012 | 2.635M |
December 31, 2011 | 1.484M |
September 30, 2011 | 2.85M |
June 30, 2011 | 3.213M |
March 31, 2011 | 2.569M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
7.227M
Minimum
Sep 2019
45.35M
Maximum
Dec 2022
16.31M
Average
12.83M
Median
Accounts Payable (Quarterly) Benchmarks
AbbVie Inc | -- |
Pfizer Inc | 5.591B |
Johnson & Johnson | 8.174B |
Merck & Co Inc | 3.514B |
Cerevel Therapeutics Holdings Inc | 10.84M |